What does LASA do? Its brands and products

Lasa Supergenerics Limited

What company does?Manufacturing and marketing of active pharmaceutical ingredients (APIs) for veterinary use

Established2008

Entity typePrivate

HeadquartersIndia

SegmentB2B

Lasa Supergenerics Limited is a share market listed company in the Healthcare industry . It got listed on NSE on 21-SEP-2017 under the trading symbol LASA. On BSE it is listed under trading symbol LASA. The company operates in Pharmaceuticals , Animal Health and Agrochemicals categories.

Company overview

Lasa Supergenerics Limited is a leading animal health company that specializes in the production of high-quality active pharmaceutical ingredients (APIs), advanced intermediates, and finished dosage forms for veterinary healthcare. The company has a strong global presence and offers an extensive range of products to cater to various therapeutic areas such as anti-infectives, anthelmintics, anti-inflammatory, analgesics, feed supplements, and growth promoters.

Their state-of-the-art manufacturing facilities are equipped with cutting-edge technology and adhere to stringent quality standards. Lasa Supergenerics focuses on research and development to introduce innovative solutions for animal care. They have a dedicated team of scientists and researchers who work tirelessly towards developing new formulations and improving existing products.

One of the key factors that make Lasa Supergenerics stand out from its competitors is its commitment to sustainability and environmental responsibility. The company follows eco-friendly practices in its manufacturing processes while ensuring the highest level of product efficacy and safety.

Lasa Supergenerics has also established strategic partnerships with global players in the animal health industry, enabling them to expand their reach and offer superior products worldwide. These collaborations further enhance their capabilities in research, manufacturing, marketing, distribution networks, regulatory affairs management, among others.

In conclusion, continues to be at the forefront of innovation by investing significantly in R&D activities focused on novel drug delivery systems which will help it maintain its competitive edge within the market.